These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

110 related items for PubMed ID: 19781773

  • 1. Deguelin suppresses cell proliferation via the inhibition of survivin expression and STAT3 phosphorylation in HTLV-1-transformed T cells.
    Ito S, Oyake T, Murai K, Ishida Y.
    Leuk Res; 2010 Mar; 34(3):352-7. PubMed ID: 19781773
    [Abstract] [Full Text] [Related]

  • 2. Resveratrol suppresses cell proliferation via inhibition of STAT3 phosphorylation and Mcl-1 and cIAP-2 expression in HTLV-1-infected T cells.
    Suzuki Y, Ito S, Sasaki R, Asahi M, Ishida Y.
    Leuk Res; 2013 Dec; 37(12):1674-9. PubMed ID: 24090995
    [Abstract] [Full Text] [Related]

  • 3. Survivin is a downstream target and effector of sulindac-sensitive oncogenic Stat3 signalling in head and neck cancer.
    Scheper MA, Nikitakis NG, Sauk JJ.
    Int J Oral Maxillofac Surg; 2007 Jul; 36(7):632-9. PubMed ID: 17566705
    [Abstract] [Full Text] [Related]

  • 4. Contribution of STAT3 to the activation of survivin by GM-CSF in CD34+ cell lines.
    Gu L, Chiang KY, Zhu N, Findley HW, Zhou M.
    Exp Hematol; 2007 Jun; 35(6):957-66. PubMed ID: 17533050
    [Abstract] [Full Text] [Related]

  • 5. YM155 suppresses cell proliferation and induces cell death in human adult T-cell leukemia/lymphoma cells.
    Sasaki R, Ito S, Asahi M, Ishida Y.
    Leuk Res; 2015 Dec; 39(12):1473-9. PubMed ID: 26547260
    [Abstract] [Full Text] [Related]

  • 6. Expression of survivin in HTLV-I-infected T-cell lines and primary ATL cells.
    Mori N, Yamada Y, Hata T, Ikeda S, Yamasaki Y, Tomonaga M, Yamamoto N.
    Biochem Biophys Res Commun; 2001 Apr 20; 282(5):1110-3. PubMed ID: 11302729
    [Abstract] [Full Text] [Related]

  • 7. Expression of functional interleukin-21 receptor on adult T-cell leukaemia cells.
    Ueda M, Imada K, Imura A, Koga H, Hishizawa M, Uchiyama T.
    Br J Haematol; 2005 Jan 20; 128(2):169-76. PubMed ID: 15638850
    [Abstract] [Full Text] [Related]

  • 8. Kahweol blocks STAT3 phosphorylation and induces apoptosis in human lung adenocarcinoma A549 cells.
    Kim HG, Hwang YP, Jeong HG.
    Toxicol Lett; 2009 May 22; 187(1):28-34. PubMed ID: 19429240
    [Abstract] [Full Text] [Related]

  • 9. Deguelin inhibits growth of breast cancer cells by modulating the expression of key members of the Wnt signaling pathway.
    Murillo G, Peng X, Torres KE, Mehta RG.
    Cancer Prev Res (Phila); 2009 Nov 22; 2(11):942-50. PubMed ID: 19861542
    [Abstract] [Full Text] [Related]

  • 10. Human leukocyte antigen-class II-negative long-term cultured human T-cell leukemia virus type-I-infected T-cell lines with progressed cytological properties significantly induce superantigen-dependent normal T-cell proliferation.
    Nagasaki M, Zhang J, Morikawa S, Harada T, Nabika T, Tanaka Y.
    Pathol Int; 2005 May 22; 55(5):264-72. PubMed ID: 15871724
    [Abstract] [Full Text] [Related]

  • 11. Implication of AMP-activated protein kinase and Akt-regulated survivin in lung cancer chemopreventive activities of deguelin.
    Jin Q, Feng L, Behrens C, Bekele BN, Wistuba II, Hong WK, Lee HY.
    Cancer Res; 2007 Dec 15; 67(24):11630-9. PubMed ID: 18089792
    [Abstract] [Full Text] [Related]

  • 12. Luteolin promotes degradation in signal transducer and activator of transcription 3 in human hepatoma cells: an implication for the antitumor potential of flavonoids.
    Selvendiran K, Koga H, Ueno T, Yoshida T, Maeyama M, Torimura T, Yano H, Kojiro M, Sata M.
    Cancer Res; 2006 May 01; 66(9):4826-34. PubMed ID: 16651438
    [Abstract] [Full Text] [Related]

  • 13. Prodigiosin down-regulates survivin to facilitate paclitaxel sensitization in human breast carcinoma cell lines.
    Ho TF, Peng YT, Chuang SM, Lin SC, Feng BL, Lu CH, Yu WJ, Chang JS, Chang CC.
    Toxicol Appl Pharmacol; 2009 Mar 01; 235(2):253-60. PubMed ID: 19133282
    [Abstract] [Full Text] [Related]

  • 14. Effects of a JAK inhibitor, AG490, on proliferation and apoptosis of human nasopharyngeal carcinoma cell line CNE-2Z.
    Wu MH, Chen XY, Cai KR.
    Ai Zheng; 2009 Jan 01; 28(1):24-8. PubMed ID: 19448411
    [Abstract] [Full Text] [Related]

  • 15. [Effect of deguelin on proliferation and apoptosis of lymphoma Daudi cells and its mechanism].
    Liu HL, Chen Y, Cui GH, Wu QL, Chen WH, He J.
    Zhonghua Zhong Liu Za Zhi; 2007 Mar 01; 29(3):176-80. PubMed ID: 17649631
    [Abstract] [Full Text] [Related]

  • 16. Bisphosphonate incadronate inhibits growth of human T-cell leukaemia virus type I-infected T-cell lines and primary adult T-cell leukaemia cells by interfering with the mevalonate pathway.
    Ishikawa C, Matsuda T, Okudaira T, Tomita M, Kawakami H, Tanaka Y, Masuda M, Ohshiro K, Ohta T, Mori N.
    Br J Haematol; 2007 Feb 01; 136(3):424-32. PubMed ID: 17233845
    [Abstract] [Full Text] [Related]

  • 17. Curcumin inhibits constitutive STAT3 phosphorylation in human pancreatic cancer cell lines and downregulation of survivin/BIRC5 gene expression.
    Glienke W, Maute L, Wicht J, Bergmann L.
    Cancer Invest; 2010 Feb 01; 28(2):166-71. PubMed ID: 20121547
    [Abstract] [Full Text] [Related]

  • 18. WP1066 disrupts Janus kinase-2 and induces caspase-dependent apoptosis in acute myelogenous leukemia cells.
    Ferrajoli A, Faderl S, Van Q, Koch P, Harris D, Liu Z, Hazan-Halevy I, Wang Y, Kantarjian HM, Priebe W, Estrov Z.
    Cancer Res; 2007 Dec 01; 67(23):11291-9. PubMed ID: 18056455
    [Abstract] [Full Text] [Related]

  • 19. Histone deacetylase inhibitors induce growth arrest and apoptosis of HTLV-1-infected T-cells via blockade of signaling by nuclear factor kappaB.
    Nishioka C, Ikezoe T, Yang J, Komatsu N, Bandobashi K, Taniguchi A, Kuwayama Y, Togitani K, Koeffler HP, Taguchi H.
    Leuk Res; 2008 Feb 01; 32(2):287-96. PubMed ID: 17644177
    [Abstract] [Full Text] [Related]

  • 20. Persistent activation of stat3 signaling induces survivin gene expression and confers resistance to apoptosis in human breast cancer cells.
    Gritsko T, Williams A, Turkson J, Kaneko S, Bowman T, Huang M, Nam S, Eweis I, Diaz N, Sullivan D, Yoder S, Enkemann S, Eschrich S, Lee JH, Beam CA, Cheng J, Minton S, Muro-Cacho CA, Jove R.
    Clin Cancer Res; 2006 Jan 01; 12(1):11-9. PubMed ID: 16397018
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.